Adjunctive β2‐agonists reverse neuromuscular involvement in murine Pompe disease-Reference-Cited by-同舟云学术

Adjunctive β2‐agonists reverse neuromuscular involvement in murine Pompe disease

Published:2012-09-19 Issue:1 Volume:27 Page:34-44
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Li Songtao¹,Sun Baodong¹,Nilsson Mats I.²³,Bird Andrew¹,Tarnopolsky Mark A.²³,Thurberg Beth L.⁴,Bali Deeksha¹,Koeberl Dwight D.¹

Affiliation:

1. Division of Medical Genetics, Department of PediatricsDuke University Medical CenterDurhamNorth CarolinaUSA

2. Department of PediatricsMcMaster University Medical CenterHamiltonOntarioCanada

3. Department of MedicineMcMaster University Medical CenterHamiltonOntarioCanada

4. Department of PathologyGenzyme Corp.FraminghamMassachusettsUSA

Funder

National Institutes of Health

National Heart, Lung, and Blood Institute

Muscular Dystrophy Association

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.12-207472

Reference56 articles.

1. Enzyme replacement and enhancement therapies for lysosomal diseases

2. Replacing acid α-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers

3. Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle

4. Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts

5. Carbohydrate‐remodeled acid alpha‐glucosidase with higher affinity for the cation‐independent mannose 6‐phosphate receptor demonstrates improved delivery to muscles of Pompe mice;Zhu Y.;Neuromusc. Dis.,2005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Is the Role of the Sympathetic System in Skeletal Muscle?;Neurology;2024-05-28

2. The Mechanism of α2 adrenoreceptor-dependent Modulation of Neurotransmitter Release at the Neuromuscular Junctions;Neurochemical Research;2023-10-28

3. Phase I study of liver depot gene therapy in late-onset Pompe disease;Molecular Therapy;2023-07

4. Lysosomal K ⁺ channel TMEM175 promotes apoptosis and aggravates symptoms of Parkinson's disease;EMBO reports;2022-08

5. Minimum Effective Dose to Achieve Biochemical Correction with Adeno-Associated Virus Vector-Mediated Gene Therapy in Mice with Pompe Disease;Human Gene Therapy;2022-05-01